Public Company News

PayMyTuition Supports Strategic Expansion in China with Selection of Fiserv to Enable Local Payment Methods for Overseas Services

SHANGHAI, May 25, 2021 /PRNewswire/ -- PayMyTuition, a leading provider of technology-driven global payment processing solutions for tuition payments, is supporting a strategic expansion inChina with the selection of Fiserv to facilitate tuition payments for Chinese students attending colleges...

2021-05-25 08:30 5442

Clinical Trial Application of ASC40 Combined with Bevacizumab to Treat Patients with Recurrent Glioblastoma Accepted by China NMPA

HANGZHOU and SHAOXING, China, May 25, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that following the consultation with China National Medical Products Administration (NMPA), the clinical trial application of ASC40 combined with bevacizumab to treat patients with re...

2021-05-25 08:30 3705

Innovent Announces First Patient Dosed in China in the Global Phase 3 Clinical Trial of Pemigatinib as the First-line Treatment of Unresectable or Metastatic Cholangiocarcinoma

SAN FRANCISCO and SUZHOU, China, May 25, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...

2021-05-25 08:00 12020

Antengene Appoints Kathryn Gregory as Vice President and Head of Corporate Business Development

SHANGHAI and HARTFORD, Conn., May 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and...

2021-05-25 08:00 4759

CLPS Incorporation Announces Strategic Cooperation with MCT, a Hong Kong Listed Company, to Develop a Next Generation Loan Trading Software

HONG KONG, May 24, 2021 /PRNewswire/ -- CLPS Incorporation (Nasdaq: CLPS) ("CLPS" or "the Company"), today announced a strategic cooperation with Minshang Creative Technology Holdings Limited ("MCT", 01632.HK) to jointly develop a next generation loan trading software and to explore global financ...

2021-05-24 20:30 7209

Biovaxys Strengthens Internal Expertise With Appointment Of Scientific Advisor For Ovarian Cancer Vaccine Clinical Program And Papilocare Marketing

VANCOUVER, British Columbia, May 24, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA: 5LB, US OTCQB: BVAXF) ("BioVaxys" or "the Company") is pleased to announce thatCharles J. Dunton, MD, has joined BioVaxys as an Advisor to help provide additional scientific support for BVX-0918A,...

2021-05-24 20:00 7864

Ping An Supports Global Poverty Alleviation, Taking Successful China Handicraft Project to Cambodia

HONG KONG and SHANGHAI, May 24, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318; SSE: 601318) announced a new poverty alleviation program forCambodia at the International Forum on Poverty Governance and Development Towards Moder...

2021-05-24 19:34 15334

Akeso's Penpulimab Monoclonal Antibody Submitted BLA in the United States

HONG KONG, May 24, 2021 /PRNewswire/ -- On May 24, 2021, Akeso, Inc. (HKEx: 9926.HK) announced that Penpulimab (research and development code: AK105), an PD-1 monoclonal antibody drug co-developed by the Company with Sino Biopharmaceutical Limited (HKEx: 1177.HK), has submitted a Biologics Licens...

2021-05-24 18:17 3584

CanSinoBIO Receives European GMP Certification for its COVID-19 Vaccine Convidecia™

* A major step for introducing Convidecia™ to more countries and people in need for protection * Vaccine has been approved in China, Mexico, Pakistan, Hungary and Chile * Provides timely clinical protection for adults aged 18 and above, including those over 60 TIANJIN, China, May 24, 2021 /P...

2021-05-24 17:00 6625

Daewoong, first-in-class PRS-inhibitor for Idiopathic Pulmonary Fibrosis (IPF) shows promising result in early stage clinical test

* We confirmed the safety of 'DWN12088' and secured grounds for establishing treatment dosage * Confirming the potential as a treatment for IPF and planning to apply for Ph.2 within 2021 * 2nd ODD granted as treatment for systemic sclerosis from the US FDA SEOUL, South Korea, May 24, 2021 /...

2021-05-24 16:59 2167

Kuaishou Technology Announces First Quarter 2021 Unaudited Financial Results

HONG KONG, May 24, 2021 /PRNewswire/ -- Kuaishou Technology (HK:1024) (the "Company" or "Kuaishou"), a leading content community and social platform, today announced its unaudited consolidated results for the first quarter of 2021 endedMarch 31, 2021 ("1Q2021"). First Quarter 2021 Key Financial ...

2021-05-24 16:50 14117

Sonata Software celebrates 30 years of relationship with Microsoft

- To further expand the relationship with a range of new growth initiatives and investments aligned to Microsoft strategy BANGALORE, India, May 24, 2021 /PRNewswire/ -- Sonata Software Ltd., a global IT services and technology solutions company, announced 30 years of relationship with Microsoft,...

2021-05-24 16:20 5800

Ericsson updates risk factors for Euro corporate bond prospectus

STOCKHOLM, May 24, 2021 /PRNewswire/ -- As previously disclosed by Ericsson (NASDAQ: ERIC) in its Q4 2020 financial report and in its 2020 annual report, there is a risk that the decision by the Post and Telecommunication Authority (PTS) to exclude Chinese vendors' products from the 5G auction in...

2021-05-24 15:21 5561

iQIYI Launches its "SWEET ON Theater" Romantic Drama Collection

BEIJING, May 24, 2021 /PRNewswire/ -- iQIYI Inc. (NASDAQ: IQ) ("iQIYI" or the "Company"), an innovative market-leading online entertainment service inChina, is pleased to announce that it has released the first series of its "SWEET ON Theater", a new collection of romantic dramas. The first serie...

2021-05-24 14:45 6018

Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID

SEOUL, Korea, May 24, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this year's European Congress of Clinical Microbiology, the ECCMID. Seegene's...

2021-05-24 09:58 2194

Payment security is key as Asia Pacific resets digital commerce in post-pandemic world

SINGAPORE, May 24, 2021 /PRNewswire/ -- Visa, the leader in digital payments, has set its focus on strengthening payments security as consumer behaviour evolves during the pandemic. Addressing more than 1,500 partners and clients in its first virtual edition of the Asia Pacific Visa Security Summ...

2021-05-24 09:10 7987

Poster to Highlight ENVASARC Pivotal Trial of Envafolimab (KN035) will be presented at the 2021 ASCO Annual Meeting

SUZHOU, China, May 24, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced the study design of the ENVASARC pivotal trial in the U.S. of Envafolimab (KN035), a recombinant humanized PD-L1 single domain antibody independently invented by Alphamab Oncology, will be presented by A...

2021-05-24 08:54 6637

Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea

Novavax and SK bioscience reaffirm partnership during meeting with South Korean leaders GAITHERSBURG, Md., May 23, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the signing of a non-...

2021-05-23 00:39 9985

Ortho Clinical Diagnostics Simultaneously Launches First Quantitative COVID-19 IgG Spike Antibody Test As Well As A Nucleocapsid Antibody Test to Help Differentiate Cause of Antibody Response

- Ortho is the only company that offers laboratories in the U.S. a quantitative test in combination with a nucleocapsid test - Both new antibody tests help health care teams differentiate the cause of antibodies against SARS-CoV-2 - Ortho's new VITROS® Anti-SARS-CoV-2 IgG Quantitative Antibody t...

2021-05-22 05:22 9879

Royal Canadian Mint Reports Profits and Performance for Q1 2021

OTTAWA, ON, May 22, 2021 /PRNewswire/ -- The Royal Canadian Mint (the "Mint") is pleased to announce its financial results for the first quarter of 2021 that provide insight into our activities, the markets influencing our businesses and our expectations for the next 12 months. "The Mint's stron...

2021-05-22 02:19 8852
1 ... 867868869870871872873 ... 894